MORGAN STANLEY - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$531,794
-39.7%
153,255
-19.2%
0.00%
Q2 2023$881,622
+32.1%
189,596
+31.3%
0.00%
Q1 2023$667,211
-63.8%
144,418
-36.6%
0.00%
Q4 2022$1,841,650
+0.1%
227,927
-31.3%
0.00%
Q3 2022$1,840,000
+6.4%
331,573
-0.2%
0.00%
Q2 2022$1,730,000
-37.9%
332,106
-2.1%
0.00%
Q1 2022$2,788,000
+194.7%
339,186
+434.2%
0.00%
Q4 2021$946,000
+91.9%
63,497
+142.9%
0.00%
Q3 2021$493,000
-86.3%
26,143
-86.5%
0.00%
Q2 2021$3,592,000
-79.6%
193,178
-75.0%
0.00%
-100.0%
Q1 2021$17,596,000
+515.9%
773,106
+487.4%
0.00%
Q4 2020$2,857,000
+2673.8%
131,620
+1177.2%
0.00%
Q3 2020$103,000
+123.9%
10,305
+74.8%
0.00%
Q2 2020$46,000
+411.1%
5,895
+601.0%
0.00%
Q1 2020$9,000
-95.4%
841
-95.2%
0.00%
Q4 2019$194,000
-11.4%
17,602
-26.8%
0.00%
Q3 2019$219,000
+2333.3%
24,042
+2824.8%
0.00%
Q2 2019$9,000
-18.2%
822
-16.0%
0.00%
Q1 2019$11,000
-87.5%
978
-90.0%
0.00%
Q4 2018$88,0009,7970.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders